Related Experiment Video

Updated: Jun 14, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines

Ron Dagan1

  • 1Pediatric Infectious Disease Unit, Soroka University Medical Center, PO Box 151, Beer-Sheva 84101, Israel. rdagan@bgumail.bgu.ac.il

Communicable Diseases Intelligence Quarterly Report
|June 17, 2003
PubMed

Insights

Pneumococcal conjugate vaccines significantly reduce invasive diseases and pneumonia in young children. Routine immunization, alongside antibiotic stewardship, is key to controlling antibiotic-resistant Streptococcus pneumoniae infections.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Streptococcus pneumoniae causes significant childhood morbidity and mortality globally.
  • Emerging antibiotic-resistant strains complicate treatment and necessitate preventative strategies.
  • Pneumococcal conjugate vaccines offer a promising solution for disease prevention in young populations.

Purpose of the Study:

  • To evaluate the efficacy of pneumococcal conjugate vaccines in preventing invasive and non-invasive pneumococcal infections.
  • To assess the impact of vaccination on antibiotic resistance and the need for antibiotics.
  • To highlight the importance of integrated strategies including vaccination, education, surveillance, and antibiotic stewardship.

Main Methods:

  • Review of existing data on pneumococcal conjugate vaccine efficacy.
  • Analysis of the impact of vaccination on disease incidence and antibiotic resistance patterns.
  • Examination of the role of routine immunization in public health.

Main Results:

  • The 7-valent pneumococcal conjugate vaccine (PCV7) demonstrates excellent efficacy against vaccine-type invasive pneumococcal disease.
  • Vaccination shows efficacy against pneumonia and otitis media caused by vaccine serotypes.
  • Evidence suggests reduced antibiotic use and spread of antibiotic-resistant pneumococci with conjugate vaccine implementation.

Conclusions:

  • Pneumococcal conjugate vaccines are effective in infants and young children, reducing disease burden.
  • Vaccination contributes to the reduction of antibiotic resistance by lowering antibiotic reliance.
  • Integrated approaches combining vaccination, education, surveillance, and judicious antibiotic use are crucial for controlling pneumococcal disease.

More Related Videos

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP009208:53

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...